DLGAP5 and cancer: Excluding mesothelioma (MESO) and uveal melanoma (UVM) without corresponding paraneoplastic tissue specimens, the pan-cancer analysis revealed that significant upregulation of DLGAP5 in 30 of 31 cancers compared to paraneoplastic tissue, but downregulation in acute myelogenous leukemia (LAML) (Figure 3(a)).